Bioafrica Bioinformatics in Africa - HIV, TB and other pathogens affecting Human Health in Africa

Introduction

BioAfrica presents the research, software and publications of Tulio de Oliveira, Sharon Cassol and members of their research groups.

Open access reports on HIV & TB drug resistance and bioinformatics in Africa

HIV & TB Drug Resistance Clinical Cases Tutorial

	Transmited Drug Resistance data now more accessible through HIVDB GIS Tool SATuRN 2012 report, date: 2012-03-29 Manasa J, Hunt G and de Oliveira T for SATuRN
	A Report of the Center for Global Development's Drug Resistance Working Group Center for Global Development Report, date: 2012-01-14 Editors: Rachel Nugent, Emma Back and Alexandra Beith
	A survey of 10 years of primary drug resistance in South Africa SATuRN 2011 report, date: 2011-12-01 Manasa J, Cassol S, Seebregts C, Newell M-L, de Oliveira T
	Surveillance of Transmitted HIV-1 Drug Resistance in South African Provinces from 2005-2009 SATuRN 2011 report, date: 2011-12-01 Hunt GM, Ledwaba J, Basson AE, Moyes J, Cohen C, Singh B, Bertagnolio S, Jordan MR, Puren A and Morris L
	HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine SATuRN 2011 report, date: 2011-12-01 Hunt GM, Coovadia A, Abrams EJ, Sherman G, Meyers T, Morris L and Kuhn L.
	Phenotypic Resistance to Etravirine in an HIV-1 Subtype-C Background SATuRN 2011 report, date: 2011-12-01 AE Basson, S-Y Rhee, CM Parry, T de Oliveira, D Pillay, R Shafer and L Morris
	In adult patients failing a second-line protease inhibitor regimen lopinavir concentration measurement in plasma or hair are helpful to exclude patients with poor adherence from unnecessary resistance testing SATuRN 2011 report, date: 2011-12-01 van Zyl GU, van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, Malavazzi C, Smith P, Huang Y, van der Merwe L, Gandhi M, Maartens G.
	SATuRN output, 15 minutes, All reports...

HIV Case 1 - Adult female with virological failure on first line d4T/3TC/EFV

HIV Case 2 - Adult female patient with virological failure on first line therapy after substitution of EFV to NVP

HIV Case 3 - Adult female patient on treatment for epilepsy with virological failure on TDF/3TC/EFV; previous single dose NVP for PMTCT

HIV Case 4 - Adult female patient with virological and immunological failure after treatment interruption for symptomatic hyperlactataemia

HIV Case 5 - Adolescent initiated on first line therapy of d4T/3TC/EFV with virological and immunological failure

Introduction

BioAfrica news

BioAfrica news - 2012-04-15

The newsletter idea is that anyone with 15 minutes to spare can learn about our work and its application in everyday life.

MSF news

MSF news - 2012-04-11

BioAfrica & SATuRN Supports this Open Letter! Open letter to the Medicines Control Council and Ministry of Health on urgent need for compassionate use of bedaquiline for XDR-TB and pre-XDRTB in South Africa.

IAS news

IAS news - 2012-03-05

by Mark Mascolini - Analysis of South Africans with newly diagnosed, untreated HIV infection indicates low levels of transmitted antiretroviral-resistant HIV across the country through 2010 and no evidence of transmitted drug-resistant HIV in rural KwaZulu Natal

UKZN news

UKZN news - 2012-02-22

BioAfrica news

BioAfrica news - 2012-01-14

Author: Lungani Ndwandwe, Tulio de Oliveira - 2012-04-20

Author: Lungani Ndwandwe, Tulio de Oliveira - 2012-03-29

Author: Richard Lessells - 2012-03-15

Author: Joshua Machao - 2012-03-14

Author: Richard Lessells - 2012-03-14

Author: Pretty Nkosi, Nokuthula Skhosana, Lungani Ndwandwe and Tulio de Oliveira - 2012-02-10

Author: Richard Lessells - 2012-01-24

Author: Richard Lessells - 2012-01-23

Author: Tulio de Oliveira - 2012-01-22

Author: Tulio de Oliveira, Lungani Ndwandwe - 2011-12-01

Author: Alisson Russell - 2011-11-02

Author: Astrid Treffry-Goatley - 2011-06-12

SATuRN 2012 report, date: 2012-03-29

Manasa J, Hunt G and de Oliveira T for SATuRN

Center for Global Development Report, date: 2012-01-14

Editors: Rachel Nugent, Emma Back and Alexandra Beith

SATuRN 2011 report, date: 2011-12-01

Manasa J, Cassol S, Seebregts C, Newell M-L, de Oliveira T

SATuRN 2011 report, date: 2011-12-01

Hunt GM, Ledwaba J, Basson AE, Moyes J, Cohen C, Singh B, Bertagnolio S, Jordan MR, Puren A and Morris L

SATuRN 2011 report, date: 2011-12-01

Hunt GM, Coovadia A, Abrams EJ, Sherman G, Meyers T, Morris L and Kuhn L.

SATuRN 2011 report, date: 2011-12-01

AE Basson, S-Y Rhee, CM Parry, T de Oliveira, D Pillay, R Shafer and L Morris

SATuRN 2011 report, date: 2011-12-01

van Zyl GU, van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, Malavazzi C, Smith P, Huang Y, van der Merwe L, Gandhi M, Maartens G.

HIV Case 1 - Adult female with virological failure on first line d4T/3TC/EFV

HIV Case 2 - Adult female patient with virological failure on first line therapy after substitution of EFV to NVP

HIV Case 3 - Adult female patient on treatment for epilepsy with virological failure on TDF/3TC/EFV; previous single dose NVP for PMTCT

HIV Case 4 - Adult female patient with virological and immunological failure after treatment interruption for symptomatic hyperlactataemia

HIV Case 5 - Adolescent initiated on first line therapy of d4T/3TC/EFV with virological and immunological failure

TB Case 1 - HIV-infected TB suspect with previous history of TB treatment: Xpert MTB/RIF test

TB Case 2 - HIV-infected TB suspect with household MDR-TB contact: Xpert MTB/RIF test

TB Case 3 - HIV-infected adult male with a laboratory report showing extensively drug-resistant TB (XDR-TB)

TB Case 4 - HIV-infected TB case with treatment failure on regimen 1 and previous unrecognised isoniazid mono-resistance

TB Case 5 - HIV-infected TB case with smear non-conversion on regimen 1 despite good adherence

BioAfrica & SATuRN Supports this Open Letter!
Open letter to the Medicines Control Council and Ministry of Health on urgent need for compassionate use of bedaquiline for XDR-TB and pre-XDRTB in South Africa.